Quarter Ended Mar 31, 2023
Net sales were $108.6 million compared to $110.5 million (up 2% in constant currency).
GAAP net income was $1.3 million, or $0.04 per diluted common share.
Adjusted EBITDA was $9.1 million compared to $8.2 million.
For complete information regarding our financials, see our periodic filings.